Navigation Links
Mission Pharmacal Company Introduces Prednisolone Sodium Phosphate Oral Solution 25mg/5mL

SAN ANTONIO, March 27, 2013 /PRNewswire/ -- For years, physicians have prescribed Prednisolone (pred NIS oh lone) in a 15 mg/5 mL standard as a rescue medicine to treat severe asthma attacks, especially in children.  Unfortunately, its taste has been so unpleasant the patient often vomits after swallowing the medication and resists further usage.  Mission Pharmacal Company has recently introduced a new flavored Prednisolone Sodium Phosphate Oral Solution 25mg/5 mL in specific markets in the United States, with plans to have the medicine available nationally as early as April 2013.


This new liquid oral solution has a "yummy" grape taste and the higher strength means lower volume for pediatric patients.  Its 40 percent less volume compared to the 15mg formula translates to ease in administration to children.  And its 8 oz. bottle provides greater flexibility in prescribing.

Dr. Dennis E. Dilley , medical director of Dilley Allergy & Asthma Specialists, LLP and a board-certified allergist/immunologist, says, "Kids actually take the medicine easily.  There's no need to force it.  They don't spit it out.  And there's no need for parents to 'chase' it with a cookie or cracker.  Its palatability means the medicine can actually be given and taken in the prescribed dosage.  An easy-to-follow chart accompanies the medicine and is very helpful."

Asthma is a disorder that causes the airways of the lungs to swell and narrow, leading to wheezing, shortness of breath, chest tightness, and coughing.  Asthma is caused by inflammation in the airways.  When an asthma attack occurs, the muscles surrounding the airways become tight and the lining of the air passages swells.  This reduces the amount of air that can pass by.[i]  As many as seven million children in the United States have asthma.  This means that for one or two kids out of 10, breathing can sometimes be difficult.  Asthma is hereditary and can surface at any age, in an infant or an adult, but is most common in school-age kids.[ii]  Medications for asthma are classified as "rescue" or "controlling."

"We are excited to offer Prednisolone Sodium Phosphate Oral Solution 25 mg," states Clint Corwin , Senior Director Pediatric Rx Products at Mission Pharmacal Company.  "We're pleased to provide a rescue medicine for those suffering an asthma attack that has a pleasant taste so kids don't balk when needing it.  The stronger formulation aids in patient compliancy."                 

Mission Pharmacal's Pediatric Sales Team is supporting the product with an aggressive, multifaceted marketing program directed to prescribing physicians and other healthcare providers, pharmacies, and patients.  Patients prescribed Prednisolone Sodium Phosphate Oral Solution will be offered a coupon through their physician's office to be redeemed at the pharmacy when the prescription is filled.  This savings coupon will result in a copay similar to the cost of a generic that has the 15mg strength.  For more information about this product, visit

About Mission Pharmacal Company

Mission Pharmacal Company is a privately held pharmaceutical company based in San Antonio, Texas.  For more than 65 years, the company has been committed to meeting the unique healthcare needs of women throughout all stages of life, pediatric patients, and those persons dealing with urologic and dermatologic conditions.  The company has a proven track record of identifying unmet healthcare needs and developing both innovative prescription and over-the-counter products to meet these needs.  Using only the purest ingredients and FDA-approved methods of manufacturing, Mission Pharmacal provides physicians and consumers with the highest quality pharmaceutical and dietary supplement products on the market today.  Mission Pharmacal is a proud national supporter of the March of Dimes Foundation®*, whose mission is to improve the health of babies by preventing birth defects, premature birth, and infant mortality.  For more information about the company, visit

[i] A.D.A.M. Medical Encyclopedia. National Center for Biotechnology Information, U.S. National Library of Medicine 8600 Rockville Pike, Bethesda MD, 20894 USA


*March of Dimes does not endorse specific products or brands.  March of Dimes is a registered trademark of the March of Dimes Foundation.


SOURCE Mission Pharmacal Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Former Clinton Deputy Solicitor General sheds light on flaws in Federal Trade Commissions case in FTC v. Actavis Inc.
2. European Commission Designates MST-188 As An Orphan Medicinal Product
3. PointCross Life Sciences SENDBox and SEND-as-a-Service Prepare Pharma Companies to Comply with the FDAs Upcoming e-Data Submission Mandate
4. Takeda presenta la richiesta di autorizzazione allimmissione in commercio nellUnione Europea per Vedolizumab nella colite ulcerosa moderata-grave e nella malattia di Crohn
5. Codonics Safe Label System and The Emily Jerry Foundation on "Mission of Safety" during National Patient Safety Week
6. United Therapeutics Announces FDA Acceptance of Resubmission of Oral Treprostinil NDA
7. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
8. Starkey Hearing Foundation Founders Bill and Tani Austin Honored by Dalai Lama After Recent Hearing Mission to India
9. Home Affairs Committees Drugs Report: Angelus Foundation Says the Prime Minister Should Not Have Rejected a Royal Commission
10. Salveo Specialty Pharmacy, Inc. Completes Additional Equity and Debt Financings and Acquisition of Mission Road Pharmacy
11. Physician-Patient Alliance for Health & Safety: Addressing The Joint Commission Opioid Warnings Can Reduce Respiratory Depression and Improve Patient Safety in Hospitals
Post Your Comments:
(Date:10/11/2017)... FRISCO, Texas , Oct. 11, 2017 /PRNewswire/ ... healthcare services, has amplified its effort during National ... patients about hereditary cancer risks. ... Journal of Clinical Oncology calculated that more than ... to have inherited mutations in BRCA1 or BRCA2 and ...
(Date:10/5/2017)... ROSEMONT, Ill. , Oct. 5, 2017 /PRNewswire-USNewswire/ ... American Association of Oral and Maxillofacial Surgeons (AAOMS) ... than opioids – to be used as a ... post-surgical pain. ... relationship, the AAOMS White Paper "Opioid Prescribing: Acute ...
(Date:10/2/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... of 2017 on Tuesday, October 24, 2017. Lilly will ... the investment community and media to further detail the ... begin at 9 a.m. Eastern time. Investors, media and ... the conference call through a link that will be ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association ... Featuring a collection of specialty vendors and unique items from across the nation, this ... health and wellness services offered by the VNA. The boutique will be open ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... ... 2017 , ... “The Journey: From the Mountains to the Mission Field”: the ... in the Philippines. “The Journey: From the Mountains to the Mission Field” is the ... She has taught all ages and currently teaches a class of ladies at her ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... ... ... IsoComforter, Inc. ( ), one of the Nation’s premier ... of the shoulder pad. The shoulder pad provides optimal support and full contact ... using cold therapy. By utilizing ice and water that is circulated from an insulated ...
Breaking Medicine News(10 mins):